Results 231 to 240 of about 1,682,964 (357)
Objective This study investigated trajectories of patient acceptable symptom state (PASS) among participants of digital education and exercise therapy for knee and hip osteoarthritis. Methods A longitudinal observational study among individuals aged at least 40 years who participated in the digital program.
Ali Kiadaliri +3 more
wiley +1 more source
STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN. VI. LUNG DIFFUSING CAPACITY, DIFFUSING CAPACITY OF THE PULMONARY MEMBRANE AND PULMONARY CAPILLARY BLOOD VOLUME IN CONGENITAL HEART DISEASE* [PDF]
Giovanni Bucci, Charles D. Cook
openalex +1 more source
Objective Systemic sclerosis (SSc) is a rare autoimmune disease characterized by tissue fibrosis, vasculopathy, and immune dysregulation. Our objectives were to quantify the overall and site‐specific cancer risks in patients with SSc compared to the general population, examine temporal trends in cancer incidence following SSc diagnosis, and explore ...
Jihyun Na +4 more
wiley +1 more source
Targeting Focal Adhesion Kinase in Lung Diseases: Current Progress and Future Directions. [PDF]
Wan Z +8 more
europepmc +1 more source
Needle Biopsy of the Lung: With Special Reference to Diffuse Lung Disease and the Use of a New Needle [PDF]
William G. Smith
openalex +1 more source
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim +18 more
wiley +1 more source
The Normal Pulmonary Angiogram and Some Changes Seen in Chronic Nonspecific Lung Disease [PDF]
G. D. Scarrow
openalex +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
Recent advances in TAM mechanisms in lung diseases. [PDF]
Ban J, Qian J, Zhang C, Li J.
europepmc +1 more source

